{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:07Z","timestamp":1787020867495,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"the National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2019R1A6A1A03032888, No.2022M3A9I2082319, and No.2022R1A2C1004718"],"award-info":[{"award-number":["2019R1A6A1A03032888, No.2022M3A9I2082319, and No.2022R1A2C1004718"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04532-x","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T13:00:52Z","timestamp":1753534852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Human embryonic stem cell-derived Sertoli cells as an immune modulator of cell transplantation therapy in a diabetic mice model"],"prefix":"10.1186","volume":"16","author":[{"given":"Jeoung Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A-Reum","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jina","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1534-4810","authenticated-orcid":false,"given":"Dong Ryul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"issue":"4","key":"4532_CR1","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM200007273430401","volume":"343","author":"AM Shapiro","year":"2000","unstructured":"Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230\u20138.","journal-title":"N Engl J Med"},{"issue":"4","key":"4532_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.2337\/diabetes.50.4.710","volume":"50","author":"EA Ryan","year":"2001","unstructured":"Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes. 2001;50(4):710\u20139.","journal-title":"Diabetes"},{"issue":"4","key":"4532_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nbt1393","volume":"26","author":"E Kroon","year":"2008","unstructured":"Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol. 2008;26(4):443\u201352.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"4532_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s11892-011-0217-8","volume":"11","author":"AM Shapiro","year":"2011","unstructured":"Shapiro AM. State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diab Rep. 2011;11(5):345\u201354.","journal-title":"Curr Diab Rep"},{"issue":"10","key":"4532_CR5","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrgastro.2017.93","volume":"14","author":"C Ellis","year":"2017","unstructured":"Ellis C, Ramzy A, Kieffer TJ. Regenerative medicine and cell-based approaches to restore pancreatic function. Nat Rev Gastroenterol Hepatol. 2017;14(10):612\u201328.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"4532_CR6","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00125-013-2955-4","volume":"56","author":"JE Bruin","year":"2013","unstructured":"Bruin JE, Rezania A, Xu J, Narayan K, Fox JK, O\u2019Neil JJ, et al. Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice. Diabetologia. 2013;56(9):1987\u201398.","journal-title":"Diabetologia"},{"key":"4532_CR7","doi-asserted-by":"crossref","unstructured":"Keymeulen B, De Groot K, Jacobs-Tulleneers-Thevissen D, Thompson DM, Bellin MD, Kroon EJ et al. Encapsulated stem cell-derived beta cells exert glucose control in patients with type 1 diabetes. Nat Biotechnol. 2024;42(10):1507\u201314.","DOI":"10.1038\/s41587-023-02055-5"},{"issue":"1","key":"4532_CR8","first-page":"3","volume":"10","author":"G Kaur","year":"2013","unstructured":"Kaur G, Mital P, Dufour JM. Testisimmune privilege - assumptions versus facts. Anim Reprod. 2013;10(1):3\u201315.","journal-title":"Anim Reprod"},{"key":"4532_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.semcdb.2016.06.018","volume":"59","author":"PG Stanton","year":"2016","unstructured":"Stanton PG. Regulation of the blood-testis barrier. Semin Cell Dev Biol. 2016;59:166\u201373.","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"4532_CR10","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1172\/JCI89927","volume":"127","author":"KS Tung","year":"2017","unstructured":"Tung KS, Harakal J, Qiao H, Rival C, Li JC, Paul AG, et al. Egress of sperm autoantigen from seminiferous tubules maintains systemic tolerance. J Clin Invest. 2017;127(3):1046\u201360.","journal-title":"J Clin Invest"},{"key":"4532_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.semcdb.2021.04.007","volume":"121","author":"RL Washburn","year":"2022","unstructured":"Washburn RL, Hibler T, Thompson LA, Kaur G, Dufour JM. Therapeutic application of Sertoli cells for treatment of various diseases. Semin Cell Dev Biol. 2022;121:10\u201323.","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"4532_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/REP-09-0384","volume":"139","author":"P Mital","year":"2010","unstructured":"Mital P, Kaur G, Dufour JM. Immunoprotective Sertoli cells: making allogeneic and xenogeneic transplantation feasible. Reproduction. 2010;139(3):495\u2013504.","journal-title":"Reproduction"},{"issue":"6","key":"4532_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/00007890-199903270-00006","volume":"67","author":"H Yang","year":"1999","unstructured":"Yang H, Wright JR. Jr. Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation. 1999;67(6):815\u201320.","journal-title":"Transplantation"},{"issue":"11","key":"4532_CR14","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.2337\/diabetes.49.11.1810","volume":"49","author":"W Suarez-Pinzon","year":"2000","unstructured":"Suarez-Pinzon W, Korbutt GS, Power R, Hooton J, Rajotte RV, Rabinovitch A. Testicular Sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism. Diabetes. 2000;49(11):1810\u20138.","journal-title":"Diabetes"},{"issue":"11","key":"4532_CR15","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1084\/jem.20090134","volume":"206","author":"F Fallarino","year":"2009","unstructured":"Fallarino F, Luca G, Calvitti M, Mancuso F, Nastruzzi C, Fioretti MC, et al. Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone. J Exp Med. 2009;206(11):2511\u201326.","journal-title":"J Exp Med"},{"issue":"1","key":"4532_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/biolre\/ioy027","volume":"99","author":"MD Griswold","year":"2018","unstructured":"Griswold MD. 50 years of spermatogenesis: Sertoli cells and their interactions with germ cells. Biol Reprod. 2018;99(1):87\u2013100.","journal-title":"Biol Reprod"},{"issue":"6","key":"4532_CR17","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1095\/biolreprod.108.071662","volume":"80","author":"EA Ahmed","year":"2009","unstructured":"Ahmed EA, Barten-van Rijbroek AD, Kal HB, Sadri-Ardekani H, Mizrak SC, van Pelt AM, et al. Proliferative activity in vitro and DNA repair indicate that adult mouse and human Sertoli cells are not terminally differentiated, quiescent cells. Biol Reprod. 2009;80(6):1084\u201391.","journal-title":"Biol Reprod"},{"issue":"3","key":"4532_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1530\/eje.1.01982","volume":"153","author":"RA Valdes-Gonzalez","year":"2005","unstructured":"Valdes-Gonzalez RA, Dorantes LM, Garibay GN, Bracho-Blanchet E, Mendez AJ, Davila-Perez R, et al. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur J Endocrinol. 2005;153(3):419\u201327.","journal-title":"Eur J Endocrinol"},{"issue":"43","key":"4532_CR19","doi-asserted-by":"publisher","first-page":"7150","DOI":"10.1038\/sj.onc.1207930","volume":"23","author":"I Chambers","year":"2004","unstructured":"Chambers I, Smith A. Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene. 2004;23(43):7150\u201360.","journal-title":"Oncogene"},{"key":"4532_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.cellbio.17.1.435","volume":"17","author":"AG Smith","year":"2001","unstructured":"Smith AG. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol. 2001;17:435\u201362.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"10","key":"4532_CR21","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1101\/gad.1303605","volume":"19","author":"G Keller","year":"2005","unstructured":"Keller G. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 2005;19(10):1129\u201355.","journal-title":"Genes Dev"},{"issue":"10","key":"4532_CR22","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1177\/0963689718797053","volume":"27","author":"DW Seol","year":"2018","unstructured":"Seol DW, Park S, Shin EY, Chang JH, Lee DR. In vitro derivation of functional Sertoli-like cells from mouse embryonic stem cells. Cell Transpl. 2018;27(10):1523\u201334.","journal-title":"Cell Transpl"},{"issue":"11","key":"4532_CR23","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3727\/096368910X513991","volume":"19","author":"JE Lee","year":"2010","unstructured":"Lee JE, Kang MS, Park MH, Shim SH, Yoon TK, Chung HM, et al. Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes. Cell Transpl. 2010;19(11):1383\u201395.","journal-title":"Cell Transpl"},{"issue":"9","key":"4532_CR24","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1172\/JCI58447","volume":"121","author":"P Ravassard","year":"2011","unstructured":"Ravassard P, Hazhouz Y, Pechberty S, Bricout-Neveu E, Armanet M, Czernichow P, et al. A genetically engineered human pancreatic beta cell line exhibiting glucose-inducible insulin secretion. J Clin Invest. 2011;121(9):3589\u201397.","journal-title":"J Clin Invest"},{"issue":"4","key":"4532_CR25","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4103\/1008-682X.163189","volume":"18","author":"MJ McCabe","year":"2016","unstructured":"McCabe MJ, Foo CF, Dinger ME, Smooker PM, Stanton PG. Claudin-11 and occludin are major contributors to Sertoli cell tight junction function, in vitro. Asian J Androl. 2016;18(4):620\u20136.","journal-title":"Asian J Androl"},{"key":"4532_CR26","doi-asserted-by":"crossref","unstructured":"Kumar N, Richter J, Cutts J, Bush KT, Trujillo C, Nigam SK et al. Generation of an expandable intermediate mesoderm restricted progenitor cell line from human pluripotent stem cells. Elife. 2015;4.","DOI":"10.7554\/eLife.08413"},{"issue":"18","key":"4532_CR27","doi-asserted-by":"publisher","first-page":"10614","DOI":"10.1073\/pnas.95.18.10614","volume":"95","author":"VJ Cristofalo","year":"1998","unstructured":"Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci U S A. 1998;95(18):10614\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"4532_CR28","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1097\/TP.0b013e318190b052","volume":"86","author":"GL Warnock","year":"2008","unstructured":"Warnock GL, Thompson DM, Meloche RM, Shapiro RJ, Ao Z, Keown P, et al. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes. Transplantation. 2008;86(12):1762\u20136.","journal-title":"Transplantation"},{"issue":"12","key":"4532_CR29","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.stem.2021.10.003","volume":"28","author":"A Ramzy","year":"2021","unstructured":"Ramzy A, Thompson DM, Ward-Hartstonge KA, Ivison S, Cook L, Garcia RV, et al. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell Stem Cell. 2021;28(12):2047\u2013e615.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"4532_CR30","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.2337\/diabetes.50.8.1691","volume":"50","author":"S Assady","year":"2001","unstructured":"Assady S, Maor G, Amit M, Itskovitz-Eldor J, Skorecki KL, Tzukerman M. Insulin production by human embryonic stem cells. Diabetes. 2001;50(8):1691\u20137.","journal-title":"Diabetes"},{"issue":"12","key":"4532_CR31","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/nbt1163","volume":"23","author":"KA D\u2019Amour","year":"2005","unstructured":"D\u2019Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol. 2005;23(12):1534\u201341.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"4532_CR32","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00125-013-2906-0","volume":"56","author":"D Jacobs-Tulleneers-Thevissen","year":"2013","unstructured":"Jacobs-Tulleneers-Thevissen D, Chintinne M, Ling Z, Gillard P, Schoonjans L, Delvaux G, et al. Sustained function of alginate-encapsulated human islet cell implants in the peritoneal cavity of mice leading to a pilot study in a type 1 diabetic patient. Diabetologia. 2013;56(7):1605\u201314.","journal-title":"Diabetologia"},{"key":"4532_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.addr.2013.07.018","volume":"67\u201368","author":"DW Scharp","year":"2014","unstructured":"Scharp DW, Marchetti P. Encapsulated islets for diabetes therapy: history, current progress, and critical issues requiring solution. Adv Drug Deliv Rev. 2014;67\u201368:35\u201373.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"4532_CR34","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nmat4290","volume":"14","author":"O Veiseh","year":"2015","unstructured":"Veiseh O, Doloff JC, Ma M, Vegas AJ, Tam HH, Bader AR, et al. Size- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates. Nat Mater. 2015;14(6):643\u201351.","journal-title":"Nat Mater"},{"issue":"3","key":"4532_CR35","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm.4030","volume":"22","author":"AJ Vegas","year":"2016","unstructured":"Vegas AJ, Veiseh O, Gurtler M, Millman JR, Pagliuca FW, Bader AR, et al. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med. 2016;22(3):306\u201311.","journal-title":"Nat Med"},{"issue":"1","key":"4532_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00009.2006","volume":"87","author":"D Wilhelm","year":"2007","unstructured":"Wilhelm D, Palmer S, Koopman P. Sex determination and gonadal development in mammals. Physiol Rev. 2007;87(1):1\u201328.","journal-title":"Physiol Rev"},{"issue":"5","key":"4532_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1387\/ijdb.130058ma","volume":"57","author":"S Oeda","year":"2013","unstructured":"Oeda S, Hayashi Y, Chan T, Takasato M, Aihara Y, Okabayashi K, et al. Induction of intermediate mesoderm by retinoic acid receptor signaling from differentiating mouse embryonic stem cells. Int J Dev Biol. 2013;57(5):383\u20139.","journal-title":"Int J Dev Biol"},{"issue":"9","key":"4532_CR38","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1242\/dev.124.9.1653","volume":"124","author":"N Miyamoto","year":"1997","unstructured":"Miyamoto N, Yoshida M, Kuratani S, Matsuo I, Aizawa S. Defects of urogenital development in mice lacking Emx2. Development. 1997;124(9):1653\u201364.","journal-title":"Development"},{"key":"4532_CR39","doi-asserted-by":"crossref","unstructured":"Washburn RL, Hibler T, Kaur G, Sabu-Kurian A, Landefeld A, Dufour JM. Immunoregulatory Sertoli cell allografts engineered to express human insulin survive humoral-mediated rejection. Int J Mol Sci. 2022;23(24).","DOI":"10.3390\/ijms232415894"},{"key":"4532_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.biomaterials.2015.10.029","volume":"75","author":"S Chiappalupi","year":"2016","unstructured":"Chiappalupi S, Luca G, Mancuso F, Madaro L, Fallarino F, Nicoletti C, et al. Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice. Biomaterials. 2016;75:313\u201326.","journal-title":"Biomaterials"},{"issue":"6","key":"4532_CR41","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/xen.12274","volume":"23","author":"G Luca","year":"2016","unstructured":"Luca G, Arato I, Mancuso F, Calvitti M, Falabella G, Murdolo G, et al. Xenograft of microencapsulated Sertoli cells restores glucose homeostasis in db\/db mice with spontaneous diabetes mellitus. Xenotransplantation. 2016;23(6):429\u201339.","journal-title":"Xenotransplantation"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04532-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04532-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04532-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T01:42:02Z","timestamp":1757295722000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04532-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4532"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04532-x","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments using hESCs were performed with authorization from the Institutional Review Board for Human Research at CHA University, Seongnam, Korea (title of the approve project: Development of cell-therapy product for the diabetes using embryonic stem cell-derived Sertoli Cells; name of the institutional approval committee: CHA University Institutional Review Board; Approval number and date: 1044308-201712-LR-050-03 (Jun. 5, 2019), 1044308-201712-LR-050-04 (Jun. 8, 2020), 1044308-201712-LR-050-06 (Jul. 14, 2021), 1044308-201712-LR-050-07,08 (Jun. 2, 2022), and 1044308-201712-LR-050-09 (Jun. 9, 2023)).The experiments using donated human periperal blood were approved by the CHA University Institutional Review Board (title of the approve project: Study for the immune reaction of human cells in vitro and i\n                      n vivo\n                      (humanized mice) with various HLA type matched blood cells derived from donated human peripheral blood and bone marrow derived blood; name of the institutional approval committee: CHA University Institutional Review Board; Approval number and date: 1044308-201803-BR-014-02 (Apr. 23,2018) and 1044308-201803-BR-014-03 (May 8, 2019)).The experimental protocols were approved by the Institutional Animal Care and Use Committee of CHA University (title of the approval project: Development of type 1 diabetes treatment using stem cell-derived insulin-secreting cells; name of the institutional approval committee: CHA University IACUC; Approval number and date: IACUC210110 (Aug. 2, 2021), IACUC220139 (Aug. 3, 2022), and IACUC230120 (Jul. 13, 2023)).The human Sertoli cells (hSCs; #4520, ScienCell, Carlsbad, CA) used for the experimental control were obtained from donors and written informed consent were obtained from the donors (\n                      \n                      ). Also, human bone marrow-derived mesenchymal stem cells (hBM-MSCs; PT-2501, Lonza, Walkersville, MD) used for the experimental control were obtained from donors and written informed consent were obtained from the donors (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"403"}}